Vantage Biosciences

Vantage Biosciences is a biotechnology company focused on developing an innovative oral therapy aimed at addressing diabetic eye diseases. The company's platform targets the underlying causes of vision loss associated with diabetes by offering a novel treatment for inflammatory conditions. This approach seeks to alleviate the significant burden of diabetic eye diseases, ultimately helping patients to protect and preserve their vision. Through its research and development efforts, Vantage Biosciences aims to provide effective solutions for individuals affected by these challenging health issues.